Connect with us

Coronavirus Thailand

Government ramps up production of 5 anti-Covid-19 medicines, procurement of others

Jack Burton

Published 

 on 

Government ramps up production of 5 anti-Covid-19 medicines, procurement of others | The Thaiger
PHOTO: La Prensa Latina
  • follow us in feedly

The Government Pharmaceutical Organisation is increasing production of five drugs used treat Covid-19 to ensure adequate stocks for all patients.

A GPO spokesmansaid that excluding Favipiravir also known as Avigan, Thailand has five drugs to treat Covid-19, totalling 39.6 million tablets: there are 1.8 million tablets of Chloroquine, an anti-malarial drug; 30.6 million tablets of an antiretroviral drug containing Lopinavir and Ritonavir, used to treat HIV/AIDS; 1.9 million tablets of the antiretroviral drug Darunavir; 1.9 million tablets of Ritonavir and 3.4 million tablets of Azithromycin, an antibiotic used to treat bacterial infections.

The spokesman says the GPO has expedited the purchase of antiviral drugs — Favipiravir and Hydroxychloroquine.

“We ordered Favipiravir from Japan and China of which 187,000 tablets have been delivered, while another 103,860 tablets will be delivered by the end of April. Meanwhile, we have already ordered 1.09 million tablets of Hydroxychloroquine from domestic manufacturers.”

SOURCE: The Nation Thailand

Keep in contact with The Thaiger by following our Facebook page.
Never miss out on future posts by following The Thaiger.

Jack Burton is an American writer, broadcaster, linguist and journalist who has lived in Asia since 1987. A native of the state of Georgia, he attended the The University of Georgia's Henry Grady School of Journalism, which hands out journalism's prestigious Peabody Awards. His works have appeared in The China Post, The South China Morning Post, The International Herald Tribune and many magazines throughout Asia and the world. He is fluent in Mandarin and has appeared on television and radio for decades in Taiwan, Mainland China, Hong Kong and Macau.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Coronavirus (Covid-19)

Experimental antiviral drug Remdesivir fails first clinical trial

Jack Burton

Published

on

Experimental antiviral drug Remdesivir fails first clinical trial | The Thaiger
PHOTO: The Edge Markets

Reports are emerging that the experimental antiviral drug Remdesivir, developed by the American pharmaceutical company Gilead Sciences, has failed in its first randomised clinical trial to treat Covid-19, according to draft documents accidentally published by the World Health Organization and seen by the Financial Times. Gilead disputed how the now deleted post characterised the findings, saying the data showed a “potential benefit.” Gilead originally developed Remdesivir as a treatment for the Ebola virus, where it showed promise at stopping the virus from replicating in clinical trials, but it was never approved. Numerous media report that researchers in China carried out […]

Continue Reading

Coronavirus (Covid-19)

Thailand imports chemicals from China to commence local production of antivirals

Anukul

Published

on

Thailand imports chemicals from China to commence local production of antivirals | The Thaiger
PHOTO: pattayamail.com

“We need to make sure we have at least 1 million pills of Favipiravir in store.” The Managing Director of Thailand’s Government Pharmaceutical Organisation Dr. Withoon Danwiboon says, “we have made contact with China to buy ‘Favipiravir’ (an antiviral drug) to start the production of the drugs locally as one of the treatments of Covid-19 virus in the country.” “We are awaiting for the antiviral delivery from China. They will arrive next week.” Favipiravir, sold under the brand name ‘Avigan’, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of […]

Continue Reading

Coronavirus Prevention & Treatment

Thai Government pharmaceutical organisation boosts production of key medicines

Anukul

Published

on

Thai Government pharmaceutical organisation boosts production of key medicines | The Thaiger
PHOTO: prachachat.net

Dr Mukdavan Prakobvaitayakit, the deputy managing director of The Government Pharmaceutical Organisation says “the GPO has been increasing the amount of production for chronic disease medication by 50%. ” This unexpected Covid-19 pandemic has hit the stockpile of 5 – 6 key medicines, which are being used in the treatment of Covid-19. In normal circumstances, GPO usually purchases raw materials and equipment to stock up for at least 6 months in advance or to slowly build up stocks for at least 2 – 3 months. Hospitals have been dispensing six-month quotas for chronic patients to cut down on congestion and […]

Continue Reading
Follow The Thaiger by email:

Trending